SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-19-000101
Filing Date
2019-09-17
Accepted
2019-09-17 17:08:44
Documents
3
Period of Report
2019-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201909178xkdoc.htm 8-K 37031
2 INDENTURE pdli-201909178xkex41.htm EX-4.1 415912
3 SUPPLEMENTAL INDENTURE pdli-201909178xkex42.htm EX-4.2 542365
  Complete submission text file 0000882104-19-000101.txt   996760
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 191097680
SIC: 2836 Biological Products, (No Diagnostic Substances)